Views & Analysis How AI, blockchain, and big data can reduce drug development... Cutting-edge technologies are increasingly improving pharma’s R&D processes.
News Medial EarlySign's AI scans medical records for kidney disea... A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
News Nearly half of life science professionals using AI - survey But lack of technical expertise holding back projects.
Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
News Budget 2017: Artificial Intelligence funds welcome, but bold... UK AI leader welcomes increased investment but suggests more needs to be done.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
